Home LiteratureArticle Details
PMID: 2536966 Published · ppublish English Case Reports Journal Article

Lack of intrahepatic recurrence of hepatocellular carcinoma by temporary portal venous embolization with starch microspheres.

Surgery ·Vol. 105 ·No. 2 Pt 1 ·1989-02-00 ·Pages 188-91

Matsumata T, Kanematsu T, Takenaka K, Sugimachi K

Abstract

Immediate recurrence in the hepatic remnant is sometimes evidenced after curative resection for treatment of hepatocellular carcinoma. One possible cause of this early recurrence is the multiple dissemination of tumor cells via the portal vein in the remnant liver as a result of surgical manipulations. In an attempt to prevent such recurrences, we performed ultrasonically guided, intraoperative portal embolization with starch microspheres in eight patients with hepatocellular carcinomas. These starch microspheres lodge only temporarily in the microvasculature, and there are no adverse effects, such as a rise in portal pressure or postoperative liver dysfunction. To date, there is no recurrence in any patient.

MeSH Terms
Adult Aged Carcinoma, Hepatocellular/diagnostic imaging,surgery Embolization, Therapeutic/methods Female Humans Intraoperative Period Liver Neoplasms/diagnostic imaging,surgery Male Microspheres Middle Aged Neoplasm Recurrence, Local/prevention & control Portal Vein Radiography Starch
Chemicals
Starch
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Matsumata T
Department of Surgery II, Kyushu University, Faculty of Medicine, Fukuoka, Japan.
Kanematsu T
Takenaka K
Sugimachi K
Article Info
Journal
Surgery
Abbr.
Surgery
ISSN
0039-6060
Published
1989-02-00
Pages
188-91
Language
English
Region
United States
NLM ID
0417347
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com